Translational Development Acquisition Corp. (TDAC)
Translational Development Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in New York City, NY, US. The stock last traded at $10.87, up 0.09% on the session, giving a market capitalisation of $267.7M. On trailing twelve-month figures it carries a trailing P/E of 42.20, a net margin of 0.0%. Its beta of 0.01 implies it has historically moved less than the broad market.
Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.
Translational Development Acquisition Corp. is most often compared with the following Financial Services names: